Lynne Saint - Illumina Non-Executive Independent Director
| ILU Stock | EUR 135.72 0.10 0.07% |
Insider
Lynne Saint is Non-Executive Independent Director of Illumina since 2019.
| Age | 56 |
| Tenure | 5 years |
| Phone | 858 202 4500 |
| Web | https://www.illumina.com |
Illumina Management Efficiency
Illumina's management efficiency ratios could be used to measure how well Illumina manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 10 records | INSIDER Age | ||
| Michelle Stewart | Eastman Chemical | 51 | |
| Mark Costa | Eastman Chemical | 57 | |
| William McLain | Eastman Chemical | 50 | |
| Brad Lich | Eastman Chemical | 55 | |
| Christopher Killian | Eastman Chemical | 53 | |
| Stephen Crawford | Eastman Chemical | 58 | |
| Perry III | Eastman Chemical | 64 | |
| Gregory Riddle | Eastman Chemical | 54 | |
| Kellye Walker | Eastman Chemical | 56 | |
| J Kuijpers | Eastman Chemical | N/A | |
Management Performance
| Return On Equity | -0.51 | |||
| Return On Asset | 0.0082 |
Illumina Leadership Team
Elected by the shareholders, the Illumina's board of directors comprises two types of representatives: Illumina inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Illumina. The board's role is to monitor Illumina's management team and ensure that shareholders' interests are well served. Illumina's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Illumina's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Julian Andrews, Head of Strategy and Planning and Head of Business Development and Group Rehabilitation | ||
| James Ranck, Non-Executive Independent Director | ||
| Francis deSouza, CEO Director | ||
| Lynne Saint, Non-Executive Independent Director | ||
| Charles Dadswell, Gen VP | ||
| Adele Stratton, General Manager - Finance, Investor Relations and Corporate Affairs | ||
| Marcelo Bastos, Independent Non-Executive Director | ||
| Susan Wilson, General Counsel, Company Secretary | ||
| Gregory Martin, Non-Executive Independent Chairman of the Board | ||
| Shane Tilka, General Manager - Jacinth-Ambrosia & Midwest | ||
| Thomas OLeary, Chief Executive Officer, Managing Director, Executive Director | ||
| Susie Corlett, Non-Executive Independent Director | ||
| Christian Barbier, Head of Marketing | ||
| Scott Ericksen, VP Officer | ||
| Kevin Pegels, Chief Operations | ||
| Nigel Tinley, Joint Company Secretary | ||
| Joydeep MBA, Chief CFO | ||
| Rob Hattingh, Chief Executive Officer - Sierra Rutile | ||
| Sallilyn Schwartz, VP Relations | ||
| Susan Tousi, Chief Officer | ||
| Daniel McGrath, General Manager - Cataby and Southwest | ||
| Matthew Blackwell, Head of Major Projects, Engineering & Innovation | ||
| Melissa Roberts, General Manager - Investor Relations and Commercial Mineral Sands Operations | ||
| Tim Bartholomew, General Manager - Strategic Development & Closure | ||
| Sarah Hodgson, General Manager - People and Sustainability | ||
| Alexander MD, CTO Devel | ||
| Stephanie Campos, President | ||
| Carissa Rollins, Chief Officer | ||
| Robert Cole, Non-Executive Independent Director |
Illumina Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Illumina a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.51 | |||
| Return On Asset | 0.0082 | |||
| Profit Margin | (0.96) % | |||
| Operating Margin | 0.04 % | |||
| Current Valuation | 32.08 B | |||
| Shares Outstanding | 158 M | |||
| Shares Owned By Insiders | 0.36 % | |||
| Shares Owned By Institutions | 93.46 % | |||
| Price To Earning | 93.17 X | |||
| Price To Book | 4.89 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Illumina Stock
When determining whether Illumina offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Illumina's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Illumina Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Illumina Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Illumina. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Illumina Stock please use our How to Invest in Illumina guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.